Leaps by Bayer

United States

Leaps by Bayer invests in paradigm-shifting advances in the life sciences and specializes in the fields of biotechnology, agriculture, and scientific breakthrough. The firm's approach is making significant and sustained investments in disruptive biotechnologies that could have the greatest impact on humanity. It was founded in 2015 andheadquartered in Leverkusen, Nordrhein-Westfalen.

Founded:2015

Firm Location:United States • Boston, Massachusetts • St. Louis, Missouri • Cambridge, Massachusetts • Berlin, Germany

Investor Firms That Co-Invest with Leaps by Bayer

Biomatics Capital Partners Agent Capital Founder Collective Domain Associates Novartis Venture Fund The Column Group Atlas Venture ARCH Venture Partners Fulcrum Global Capital Innova Memphis Longwood Fund MRL Ventures Fund Lever VC Cofounders Capital Soffinova Partners Lux Capital Polaris Partners

Leaps by Bayer Team

Photo of Paimun Amini, Investor at Leaps by Bayer

Leaps by Bayer·Investor

Sweet spot: $1.5M

Range: $100K - $5.0M

Investors in Berlin (Germany)

Investors in AgTech (Series B), Investors in AgTech (Series A), Investors in BioTech (Series B), Investors in AgTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Midwest (Other Lists)

to see your intro paths to Paimun

Photo of Lee Cooper, Investor at Leaps by Bayer

Leaps by Bayer·Investor

Sweet spot: $1.5M

Range: $100K - $5.0M

Investors in Germany

Investors in Medical Devices (Seed), Investors in AgTech (Series A), Investors in Pharmaceuticals (Seed), Investors in AgTech (Seed), Investors in Consumer Health (Series A), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in Consumer Health (Seed), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Boston / New England (Other Lists), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)

to see your intro paths to Lee

Photo of Rakhshita Dhar, Investor at Leaps by Bayer

Leaps by Bayer·Investor

Sweet spot: $1.5M

Range: $100K - $5.0M

Investors in Berlin (Germany)

Investors in AgTech (Series B), Investors in AgTech (Series A), Investors in BioTech (Series B), Investors in AgTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Boston / New England (Other Lists)

to see your intro paths to Rakhshita

Photo of Lucio Iannone, Vice President at Leaps by Bayer

Leaps by Bayer·Vice President

Sweet spot: $1.5M

Range: $100K - $5.0M

Investors in Berlin (Germany)

Investors in AgTech (Series B), Investors in AgTech (Series A), Investors in BioTech (Series B), Investors in AgTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Boston / New England (Other Lists)

to see your intro paths to Lucio

Photo of Naveen Krishnan, Investor at Leaps by Bayer

Naveen Krishnan

Leaps by Bayer·Investor

Sweet spot: $1.5M

Range: $100K - $5.0M

Investors in Berlin (Germany)

Investors in AgTech (Series B), Investors in AgTech (Series A), Investors in BioTech (Series B), Investors in AgTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A)

to see your intro paths to Naveen

Photo of Derek Norman, Vice President at Leaps by Bayer

Leaps by Bayer·Vice President

Sweet spot: $1.5M

Range: $100K - $5.0M

Investors in Berlin (Germany)

Investors in AgTech (Series B), Investors in AgTech (Series A), Investors in BioTech (Series B), Investors in AgTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A)

to see your intro paths to Derek

Photo of Fabio Pucci, Investor at Leaps by Bayer

Leaps by Bayer·Investor

Sweet spot: $1.5M

Range: $100K - $5.0M

Investors in Berlin (Germany)

Investors in AgTech (Series B), Investors in AgTech (Series A), Investors in BioTech (Series B), Investors in AgTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Boston / New England (Other Lists)

to see your intro paths to Fabio

Photo of Ryan D. Teksten, Investor at Leaps by Bayer

Ryan D. Teksten

Leaps by Bayer·Investor

Sweet spot: $1.5M

Range: $100K - $5.0M

Investors in Berlin (Germany)

Investors in AgTech (Series B), Investors in AgTech (Series A), Investors in BioTech (Series B), Investors in AgTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Boston / New England (Other Lists)

to see your intro paths to Ryan D.